BOSNALIJEK / ABOUT US
Leading Pharmaceutical Company in Bosnia and Herzegovina
We are dedicated to the development of preventive action, palliation and cures and to improving the quality of life.
READ MORE
QUALITY, SAFETY AND EFFICACY
Continuously committed to the needs of our customers
We are committed to the continuous and consistent application of quality standards in all aspects of our business operations and processes.
READ MORE
CAREER / EDUCATION AND DEVELOPMENT
Our employees make our business successful
We devote special attention to talent management, career development and succession planning for key organisational positions.
READ MORE
BOSNALIJEK / SOS CHILDREN’S VILLAGES
We invest in our children’s healthy and carefree living
The second generation of children is being raised in an SOS children’s village family supported by Bosnalijek.
READ MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Investors
We are committed to meeting the expectations of our customers, shareholders and employees
MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Career
Join our family and make your contribution to improving the health of people around the world
MORE
PRESS CENTRE / CORPORATE MOVIE
Bosnalijek is a proof that the bravest visions live
In its decades-long business, Bosnalijek has been committed to consistently applying quality in all business operations and processes. Therefore, it produces top quality medicines and ranks among internationally competitive pharmaceutical companies.

The quality system of Bosnalijek is fully compliant with national and international legal regulations and Good Manufacturing Practice standards, which justifies the expectations of users, partners and regulatory bodies.
PRESS CENTAR / NEWS
Bosnalijek for the 21st Century

On Wednesday 28 March, Bosnalijek d.d. (Bosnalijek), the leading pharmaceutical company in Bosnia and Herzegovina, inaugurated a new Quality Control facility in Sarajevo.
In detail
PRESS CENTAR / NEWS
Bosnalijek achieves Record Turnover of 107 million BAM in Foreign Markets
Bosnalijek recorded great business results in 2017, further underlining its reputation as the leading pharmaceutical company in Bosnia and Herzegovina (BiH)...
In detail
PRESS CENTAR / NEWS
Postgraduate Students from the American University Yale visit Bosnalijek
During the corporate presentation, the MBA students asked numerous questions. They were particularly interested in the company, its work method and ...
In detail
maj 28. 2018 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%